Order Article Reprints

Verma S, Younus J, Haynes AE, Stys-Norman D, Blackstein M, the Members of the Sarcoma Disease Site Group, Cancer Care Ontario’s Program in Evidence-Based Care. Dose-Intensive Chemotherapy with Growth Factor or Autologous Bone Marrow or Stem-Cell Transplant Support in First-Line Treatment of Advanced or Metastatic Adult Soft Tissue Sarcoma: A Clinical Practice Guideline. Current Oncology. 2008; 15(2):80-84. https://doi.org/10.3747/co.v15i2.162

Verma, S., J. Younus, A. E. Haynes, D. Stys-Norman, M. Blackstein, the Members of the Sarcoma Disease Site Group, and Cancer Care Ontario’s Program in Evidence-Based Care. 2008. "Dose-Intensive Chemotherapy with Growth Factor or Autologous Bone Marrow or Stem-Cell Transplant Support in First-Line Treatment of Advanced or Metastatic Adult Soft Tissue Sarcoma: A Clinical Practice Guideline" Current Oncology 15, no. 2: 80-84. https://doi.org/10.3747/co.v15i2.162

Verma, S., Younus, J., Haynes, A. E., Stys-Norman, D., Blackstein, M., , the Members of the Sarcoma Disease Site Group, & , Cancer Care Ontario’s Program in Evidence-Based Care. (2008). Dose-Intensive Chemotherapy with Growth Factor or Autologous Bone Marrow or Stem-Cell Transplant Support in First-Line Treatment of Advanced or Metastatic Adult Soft Tissue Sarcoma: A Clinical Practice Guideline. Current Oncology, 15(2), 80-84. https://doi.org/10.3747/co.v15i2.162